Author:
Friedrich Maurício André Gheller,Mannetti Euler Roberto,Martins Sheila Ouriques
Abstract
O Acidente Vascular Cerebral Isquêmico(AVCI) é a maior causa de incapacidades físicas e cognitivas em nosso meio. O uso da terapia trombolítica com rt-PA na fase aguda eleva significativamente a chance de uma recuperação completa. Os hospitais que tratam pacientes com AVC agudo devem ser preparados para o uso desta terapêutica. Neste artigo mostramos a seqüência, o modelo operacional e alguns resultados da implantação do protocolo rt-PA em dois hospitais de referência em Porto Alegre-RS.
Publisher
Universidade Federal de Sao Paulo
Subject
Neurology (clinical),Neurology
Reference15 articles.
1. Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke (Cochrane Review). In: The Cochrane Library, Issue 1, 2003.
2. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.
3. Update on intravenous tissue plasminogen activator for acute stroke: from clinical trials to clinical practice. Can Med Assoc J. 2001;165:311–317.
4. Hacke W, Kaste, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P, for the Second European-Australasian Acute Stroke Study Investigators. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet. 1998;352:1245–1251.
5. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, Haley EC Jr, Lewandowski CA, Kwiatkowski TP, for the NINDS rt-PA Stroke Study Group. Early stroke treatment associated with better outcome. Neurology. 2000;55:1649–1655.